![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Sintefina Industria E Comercio Ltda Diadema, Sao Paulo Br, based in Brazil, is a pharmaceutical company.
One of their significant offerings is Bromazepam, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 1998-150 - Rev 02
This Chemical Type CEP, issued on July 03, 2007, remains in force until April 11, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 879 associated with this CEP further emphasizes